SFCML
Seven Fleet Capital Management LP Portfolio holdings
AUM
$131M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$131M
AUM Growth
–
Holding
85
Top Buys
| 1 | +$62.7M | |
| 2 | +$60.5M | |
| 3 | +$7.13M | |
| 4 |
Revolution Medicines
RVMD
|
+$4.31M |
| 5 |
Exelixis
EXEL
|
+$2.84M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATXS
76
DELISTED
Astria Therapeutics
ATXS
| $52.4K | 0.04% |
+4,000
|
|
||
77
Edgewise Therapeutics
EWTX
$3.14B
| $49.6K | 0.04% |
+2,000
|
|
||
78
VistaGen Therapeutics
VTGN
$24M
| $41.5K | 0.03% |
+62,701
|
|
||
79
Enanta Pharmaceuticals
ENTA
$418M
| $35.8K | 0.03% |
+2,270
|
|
||
80
Cullinan Oncology
CGEM
$899M
| $31.1K | 0.02% |
+3,000
|
|
||
|
GBIO
81
DELISTED
Generation Bio
GBIO
| $30.5K | 0.02% |
+5,376
|
|
||
82
Beam Therapeutics
BEAM
$2.93B
| $9.34K | 0.01% |
+337
|
|
||
83
Eledon Pharmaceuticals
ELDN
$193M
| $9.06K | 0.01% |
+6,000
|
|
||
|
ABVX
84
Abivax
ABVX
$9.45B
| $1.62K | ﹤0.01% |
+12
|
|
||
85
Vir Biotechnology
VIR
$1.3B
| $1.21K | ﹤0.01% |
+200
|
|